Cord tissue refers to the actual umbilical cord. Scientists have found that your baby’s umbilical cord is an exceptional source of valuable stem cells.
Umbilical cord tissue stem cells are vastly different from cord blood stem cells, but equally important. Banking cord tissue stem cells can be extremely valuable for stem cell therapies and future disease treatment.
Cord tissue stem cells, also known as Mesenchymal Stem Cells or MSCs, are found in the Wharton’s Jelly and perivascular regions of the umbilical cord.
MSCs are showing great potential in the fields of regenerative medicine, tissue engineering and gene therapy. They are a different kind of stem cell from the hematopoietic stem cells (HCSs) found in cord blood, and they can differentiate into a variety of cell types, including bone, cartilage, muscle, nerve and others.
Because of their versatility, MCSs in cord tissue stem cells may have the potential to treat even more than the 80 diseases and conditions that are already FDA-approved for treatment with cord blood stem cells.
Mesenchymal stem cells from cord tissue represent the most advanced, cutting-edge discoveries in regenerative medicine today.
The use of cord tissue stem cells has the enormous potential to make regenerative medicine a life-saving reality. This is something that conventional medicine and pharmaceutical therapy have not been able to do effectively.
With over 300 MSC clinical trials and numerous research studies in process, scientists predict there will be an explosion of new therapies using cord tissue stem cells, as they represent the most advanced, cutting-edge discoveries in regenerative medicine today.
It is anticipated that new therapies will be universally adopted, and include standard, routine treatments for autism, type 1 diabetes, Alzheimer’s, spinal cord injury, traumatic brain injury, Parkinson’s disease, rheumatoid arthritis, multiple sclerosis, stroke, heart failure, liver damage and many more.
Furthermore, the ability of cord tissue stem cells to suppress the body’s immune response has prompted doctors to transplant them in unison with cord blood stem cells to potentially reduce the effects of transplant rejection or Graft Versus Host Disease (GVHD). By using cord tissue stem cells along with cord blood stem cells, researchers have also reported quicker cell engraftment and improved transplant outcomes.
Some of the Clinical Trials Using MSCs:
Private banking of both cord blood and cord tissue will provide your family with the most complete scope of future treatment options.